ZA200605583B - Use of gallium to treat inflammatory arthritis - Google Patents

Use of gallium to treat inflammatory arthritis

Info

Publication number
ZA200605583B
ZA200605583B ZA200605583A ZA200605583A ZA200605583B ZA 200605583 B ZA200605583 B ZA 200605583B ZA 200605583 A ZA200605583 A ZA 200605583A ZA 200605583 A ZA200605583 A ZA 200605583A ZA 200605583 B ZA200605583 B ZA 200605583B
Authority
ZA
South Africa
Prior art keywords
gallium
inflammatory arthritis
treat inflammatory
treat
arthritis
Prior art date
Application number
ZA200605583A
Other languages
English (en)
Inventor
Louis R Bucalo
Sreedharan Sunil
Allamneni Krishna
Lawrence R Bernstein
Original Assignee
Titan Pharmaceuticals Inc
Lawrence R Bernstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Titan Pharmaceuticals Inc, Lawrence R Bernstein filed Critical Titan Pharmaceuticals Inc
Publication of ZA200605583B publication Critical patent/ZA200605583B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200605583A 2003-12-17 2004-12-17 Use of gallium to treat inflammatory arthritis ZA200605583B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53035303P 2003-12-17 2003-12-17

Publications (1)

Publication Number Publication Date
ZA200605583B true ZA200605583B (en) 2009-06-24

Family

ID=34700126

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200605583A ZA200605583B (en) 2003-12-17 2004-12-17 Use of gallium to treat inflammatory arthritis

Country Status (9)

Country Link
US (1) US20050220895A1 (enExample)
EP (1) EP1694341A1 (enExample)
JP (1) JP2007514754A (enExample)
CN (1) CN1917889A (enExample)
AU (1) AU2004299126A1 (enExample)
CA (1) CA2550119A1 (enExample)
MX (1) MXPA06006801A (enExample)
WO (1) WO2005058331A1 (enExample)
ZA (1) ZA200605583B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119217B2 (en) * 2002-09-23 2006-10-10 Genta Incorporated Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing them
WO2007100382A2 (en) * 2005-10-27 2007-09-07 Bernstein Lawrence R Orally administrable gallium compositions and method of use
WO2007053581A2 (en) 2005-11-01 2007-05-10 Sideromics, Llc Growth control of oral and superficial microorganisms using gallium compounds
CN101300033A (zh) * 2005-11-07 2008-11-05 泰坦医药品公司 用镓对不良肝脏病症的治疗和预防
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
WO2008058210A2 (en) * 2006-11-09 2008-05-15 Bernstein Lawrence R Local administration of gallium compositions to treat pain
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
US8895077B2 (en) * 2007-04-02 2014-11-25 Mount Sinai School Of Medicine Methods for preventing or treating infectious diseases caused by extracellular microorganisms, including antimicrobial-resistant strains thereof, using gallium compounds
EP2262509A4 (en) * 2008-03-07 2012-02-22 Lawrence Bernstein GALLIUM COMPOUNDS AND METHOD OF USE FOR THE TREATMENT OF INFLAMMATORY ENDURANCE
CA2727432C (en) 2008-06-12 2016-10-11 Medtronic Xomed, Inc. Method for treating chronic wounds with an extracellular polymeric substance solvating system
US20100086576A1 (en) * 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
AU2010232694B2 (en) * 2009-03-30 2016-08-04 Altum Pharmaceuticals, Inc. Method of treating osteoporosis
US10653133B2 (en) 2011-05-10 2020-05-19 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
WO2017156194A1 (en) * 2016-03-08 2017-09-14 The Regents Of The University Of California Compositions and methods for inhibiting influenza rna polymerase pa endonuclease
US10889556B2 (en) 2016-03-08 2021-01-12 The Regents Of The University Of California Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease
EP3582778B1 (en) * 2017-02-10 2022-10-05 MedMelior Inc. Compositions of gallium (iii) complexes for oral administration
US10537661B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same
US10537658B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
US11690806B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
MX2020012458A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
WO2022231930A1 (en) 2021-04-26 2022-11-03 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519361A1 (de) * 1985-05-30 1986-12-04 Boehringer Ingelheim International GmbH, 6507 Ingelheim (gamma)-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen
EP0330799A1 (en) * 1988-03-03 1989-09-06 Schering Aktiengesellschaft A method for the treatment of arthritis and inflammatory joint diseases
US6004951A (en) * 1989-11-22 1999-12-21 Bernstein; Lawrence Richard Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
US5258376A (en) * 1989-11-22 1993-11-02 Bernstein Lawrence R Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US5175006A (en) * 1990-09-21 1992-12-29 The Ohio State University Method of treating arthritis using gallium compounds
ATE166056T1 (de) * 1991-07-25 1998-05-15 Philippe Collery Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
EP0612246B1 (en) * 1991-11-12 2000-08-30 BERNSTEIN, Lawrence Richard Dr. Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US5902825A (en) * 1997-01-07 1999-05-11 Mitreoak, Ltd. Composition and method for the palliation of pain associated with diseases of the bone and bone joints
US6303804B1 (en) * 1999-05-07 2001-10-16 Raytheon Company Environmentally benign bismuth-containing spin-on precursor materials
US6054600A (en) * 1999-05-07 2000-04-25 Raytheon Company Non-toxic solvent soluble group IV and V metal acid salt complexes using polyether acid anhydrides
US20020068761A1 (en) * 1999-10-04 2002-06-06 Bernstein Lawrence R. Gallium complexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
JP2003510362A (ja) * 1999-10-04 2003-03-18 ローレンス・アール・バーンスタイン 細胞内原核生物、ｄｎａウイルス及びレトロウイルスによる感染を治療するための、３−ヒドロキシ−４−ピロンのガリウム錯体

Also Published As

Publication number Publication date
WO2005058331A1 (en) 2005-06-30
AU2004299126A1 (en) 2005-06-30
CA2550119A1 (en) 2005-06-30
CN1917889A (zh) 2007-02-21
MXPA06006801A (es) 2007-01-26
US20050220895A1 (en) 2005-10-06
EP1694341A1 (en) 2006-08-30
JP2007514754A (ja) 2007-06-07

Similar Documents

Publication Publication Date Title
ZA200605583B (en) Use of gallium to treat inflammatory arthritis
ZA201207322B (en) Method of treatment of prophylaxis
EP1494990A4 (en) IMPROVED LIQUID COMPOSITIONS
EP1663222A4 (en) METHODS RELATING TO THE TREATMENT OF GIANCES
PT1791791T (pt) Métodos e composições para tratamento de água
PT1694342T (pt) Métodos de utilização de gelsolina para tratar ou prevenir sepsia bacteriana
GB2408558B (en) Treatment of pipes
IL185114A0 (en) Use of vitamin d compounds to treat endometriosis
PL373523A1 (en) Indol-2-ones as selective inhibitors of cyclooxygenase-2
EP1912630A4 (en) COMPOSITIONS AND METHODS FOR REDUCING POSTOPERATIVE PAIN
EP1651643A4 (en) BICYCLIC COMPOUNDS AND COMPOSITIONS USED AS PDF INHIBITORS
PT1611068E (pt) Uso de dispersantes para melhorar a manutenção da fluidez do betão
HK1090568A (en) Use of gallium to treat inflammatory arthritis
IL164218A0 (en) Use of interleukin-19 to treat ovarian cancer
GB0408521D0 (en) Treatment of sepsis
FR2851494B1 (fr) Perfectionnement aux fendeuses de buches
GB0327975D0 (en) Methods of treatment
AU2003224720A8 (en) Use of resistin to treat hematopoietic disorders
ZA200406777B (en) Production of abalone
GB0301609D0 (en) Improvements to power blocks
GB0319717D0 (en) Adding disinfectant to water
GB0302549D0 (en) Treatment of ferrous waste
GB0318862D0 (en) Improvments to self-sterilisation of surfaces
GB0316556D0 (en) Treatment of water
GB0409840D0 (en) Improvements to self-sterilisation of surfaces